Caregen (214370) Fundamentals 2026 — P/E 98.7x, Revenue Analysis | SniperIQ
Caregen (214370) is a KR-listed Basic Materials company in Chemicals with a market capitalization of ₩2.69T, trading at ₩55100.00 on the KOE. This SniperIQ fundamentals page covers Caregen's valuation (P/E 98.7x, P/B 13.8x), profitability (net margin 36.9%), revenue (₩72.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Caregen's market cap?
Caregen (214370) has a market capitalization of approximately ₩2.69T, trading at ₩55100.00 on the KOE. Market cap moves with the live share price.
What is Caregen's P/E ratio?
Caregen's trailing twelve-month P/E ratio is 98.7x, with a price-to-book (P/B) of 13.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Caregen?
Caregen runs a net profit margin of 36.9%, a gross margin of 70.5%, and an operating margin of 34.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Caregen generate?
Caregen reported revenue of ₩72.8B for fiscal year 2025, with net income of ₩20.1B and earnings per share (EPS) of 411. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Caregen pay a dividend?
Caregen offers a trailing dividend yield of about 0.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Caregen financially healthy?
Caregen carries a debt-to-equity ratio of 0.00x and a current ratio of 4.80x, with a market beta of 0.67. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Caregen a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Caregen (214370) the key facts are: market cap ₩2.69T, P/E 98.7x, revenue ₩72.8B, 52-week range 44400-153800. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Caregen's full fundamentals live
Get Caregen's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.